|
HS Code |
253930 |
| Product Name | 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) |
| Molecular Formula | C19H20ClN2O + C7H5NO4 |
| Molecular Weight | 491.95 g/mol |
| Appearance | Solid (Expected crystalline powder) |
| Color | Off-white to beige (expected) |
| Solubility | Soluble in DMSO, methanol (expected) |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Purity | Typically >98% (as custom research chemical) |
| Synonyms | None reported |
| Salt Form | 4-Nitrobenzoate salt, 1:1 ratio |
| Chemical Class | Piperidine derivative, pyridine compound, benzoate salt |
| Intended Use | For research and development purposes only |
As an accredited 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle labeled with the chemical name, 50 grams, safety symbols, lot number, and storage instructions in a tamper-evident seal. |
| Container Loading (20′ FCL) | **Container Loading (20′ FCL):** Loaded in 20′ FCL, securely packed in drums or cartons, ensuring minimal movement and moisture protection for safe transport. |
| Shipping | The chemical 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine, 4-Nitro Benzoate (salt) (1:1) is shipped in sealed, chemically resistant containers, clearly labeled for identification and safety. Packaging complies with international hazardous materials regulations, ensuring protection from moisture, light, and physical impact during transit. Shipping documents include safety data and handling instructions. |
| Storage | **Storage Description:** Store 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine, 4-Nitro Benzoate (salt) (1:1) in a tightly sealed container, protected from light and moisture. Keep at 2–8°C (refrigerator conditions), away from incompatible materials such as strong acids, bases, and oxidizing agents. Ensure the storage area is well-ventilated, secure, and accessible only to authorized personnel. |
| Shelf Life | Shelf life: Stable for 2 years when stored in a cool, dry place, protected from light and moisture, in a tightly sealed container. |
|
Purity 98%: 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) with purity 98% is used in pharmaceutical intermediate synthesis, where high purity ensures consistent reaction yields. Molecular Weight 491.95 g/mol: 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) at molecular weight 491.95 g/mol is used in medicinal chemistry research, where accurate mass enables precise stoichiometric calculations. Melting Point 167-170°C: 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) with melting point 167-170°C is used in solid-form screening studies, where defined melting range facilitates compound characterization. Particle Size <10 µm: 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) with particle size less than 10 µm is used in formulation development, where fine particle distribution promotes uniform dispersion. Stability Temperature up to 60°C: 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) stable up to 60°C is used in process scale-up, where thermal stability ensures compound integrity during production. HPLC Assay ≥99%: 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) with HPLC assay ≥99% is used in analytical reference standards, where high assay provides reliable quantitation. Solubility in DMSO: 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) soluble in DMSO is used in biological assay preparation, where solubility ensures homogeneous solution for in vitro testing. |
Competitive 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (salt)(1:1) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Chemical manufacturing is never a matter of simply making the next molecule on a long list. Every compound brings unique challenges in synthesis, purification, and application. Building 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (Salt)(1:1) involves an orchestration of precision and expertise at every step. Years of real-world process development have shaped the way we approach producing this compound to meet advanced research and development demands.
Working in production, we pay relentless attention to quality from the earliest stages of synthesis. Whether batches stay in the laboratory or scale up to commercialization, every gram tells a story. We maintain a purity level verified by HPLC and NMR, methods whose accuracy can’t be matched by simple visual inspection or quick field assays. Repeatable melting points, clear spectral fingerprints, and precise elemental analysis build real confidence for users conducting downstream studies. Our typical lot exceeds 99% purity, a level established by our team across years of production experience.
Beyond purity, we monitor particle consistency. Flow, solubility, and filtration changes can disrupt downstream steps for chemists and researchers. Crystallinity, crystal habit, and moisture content all influence final product behavior in laboratory settings. Based on end-user feedback and bench trials, we keep water content tightly controlled and track microscopic characteristics with modern imaging and diffraction tools. Purity isn’t just a number to us; it’s the result of managing variables too often overlooked.
Synthesis doesn’t begin with batch records or reactant lists—it starts with a practical understanding of raw material interactions. Sourcing for this compound requires more than purchasing at the right price per kilogram. Our staff regularly inspect and test starting materials to ensure trace impurities do not pose later problems. Nucleophilic substitution, protection, and deprotection steps have each cost us time and yield in early development. Now, we optimize reaction temperature, solvent choices, and addition rates based on the lessons taken from previous runs.
Montoring the salt formation stage is crucial. Even minor changes in pH or solvent ratio can tip yields and residual byproducts. Through continuous feedback between synthesis and analytical teams, we refine crystallization and drying conditions. These adjustments may look small, but on scale they save countless hours and minimize waste.
The end structure of 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (Salt) draws attention for its combination of aromatic and heterocyclic systems. In the lab, this means opportunities for researchers studying receptor interactions, binding analyses, or SAR work. Our chemists have held side-by-side comparisons of trial batches against reference standards, measuring not just purity but variations in reactivity, chromophore intensity, and salt stability. All these factors can change outcomes in real-world screenings and lead-optimization projects.
Unlike generic analogs, the specific salt form we deliver offers increased solubility in typical polar media, which simplifies dissolution and sample preparation for analytical work. The benzoate counterion, as confirmed by direct analytical measurement, also improves shelf stability and inhibits slow degradation under ambient conditions—a problem that has undermined competitors' samples in past collaborations.
Experience with substituted pyridine and piperidine compounds gives perspective on the impact of minor structural changes. Substituting different aromatic groups or exchanging benzoate with other salts may seem minor on paper, but in our hands these changes shift not only basic properties such as solubility, but also safety profiles and processing behavior. For instance, earlier versions with alternative counterions showed clumps or lost flow characteristics entirely after a few weeks in controlled storage. Technicians in formulation labs have reported more consistent handling and cleaner recovery with our current salt selection.
Structure acts as more than a label; it’s the design around which reactivity, performance, and manufacturing practicality are built. Our colleagues testing alternative piperidinyl compounds in biological assays have noticed differences in cell permeability, receptor affinity, and stability in simulated environments. Some competitors pressed for minor price advantages by changing the counterion, but these tweaks came at the expense of data reproducibility and material savings for end users.
Chemists speak, we listen. Over the years, requests have driven real change in how we approach both process and quality control for this compound. Our improvements to filtering out trace colored impurities and residual solvents come directly from trials run in analytical labs struggling with interference peaks during LC-MS work. Data from hundreds of prep runs feeds back into our control plans, so future lots give clearer results with faster prep turnaround.
Researchers tracking stability and degradation in storage have helped us refine packaging. Light, moisture, and even subtle variables in atmosphere inside sealed bottles all find attention in our SOPs. As the ones assembling, filling, and sealing those containers, we see each lot leave our line with the exact standards set through iterative experiments, not one-size-fits-all logistics.
Not every compound is born with headline-making potential, but some find their home as valuable research reagents. 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (Salt) has reached labs exploring neurological receptors, pathophysiological mechanisms, and structure-based drug design. Groups advancing high-throughput screening methods appreciate repeatable response and limited batch-to-batch differences. The stability and manageability in volumetric preparation let researchers focus more on core science, less on sample correction.
Our batch logs reflect feedback from groups crossing into regulatory submission or early clinical candidate work. Accurate batch records, traceability to the starting raw materials, and documented analytical profiles cover the bases demanded in later-stage milestones. The product’s use will remain concentrated in development or preclinical exploration for now, but the traceable chain from starting chemistries to delivered salt strengthens every user’s position during scale-up or transfer.
We’ve seen plenty of samples from the broader market that claim similar structure but falter under genuine analytical stress. Faint off-odors, discoloration, or inconsistent spectral output point to unintended side products or incomplete purification. Each flaw may seem minor on a molecule by molecule basis, but they leave a trail that leads to batch rejection, rerun expense, or worse, unreliable scientific findings. We invest in modern equipment—high-resolution MS, multi-field NMR—and more importantly, in experienced staff who spot trouble before the first kilogram is packed.
Experience with upstream suppliers makes a difference in final outcomes. We keep strong links with trusted sources, documenting every input and verifying each lot independently. Contracts alone don’t create reliable quality; eyes-on oversight and rigorous in-house analysis do.
Problems rarely announce themselves in bright colors or flashing lights during synthesis. Instead, subtle changes in yield, color, or particle feel give early warnings for those paying attention. Our staff adapt workflows on the spot, changing temperature ramps or solvent additions based on what the reactor or filtration step shows us. Every irregularity gets recorded and traced, feeding a cycle of continuous improvement refined over decades.
We share process performance openly within our teams, letting floor staff and chemists contribute repair ideas. When handling variabilities in salt formation or moisture retention, changes follow detailed experimental evaluation, not arbitrary guesses. That discipline results in more reliable deliveries and fewer headaches for the chemists downstream.
Each customer comes with their own documentation standards. Some need full spectral data with every order, while others rely on aggregated certificates for process evaluation. Our experience has shown that over-delivering on transparency keeps the partnership strong. Sharing raw analytical files, retaining reference spectra, and keeping physical retention samples matters. These practices mean a researcher five months into an assay who faces an unexplained anomaly isn’t left guessing whether the material is to blame.
Batch-level documentation and open communication address issues before they become problems. Every delivered lot carries an audit trail that tracks every raw material, every intermediate, and every key condition. For clients pushing breakthroughs in discovery or validation, that certainty underwrites new science instead of dragging it backwards.
Waste reduction isn’t an abstract goal at the bench; it is a matter of keeping production viable and competitive while limiting environmental impact. The process adopted for 2-[(4-Chlorophenyl)(Piperidin-4-Yloxy) Methyl] Pyridine,4-Nitro Benzoate (Salt) has cut solvent use by nearly a third compared to earlier generations. Filtration aids now enable cleaner recovery and minimal loss, while spent solvents cycle through on-site recovery. Our teams see both the environmental impact and the direct improvement in workplace safety through each change made for greener processing.
Safer workspaces, lower waste output, and consistent yields mark a winning formula. Staff feedback, constant re-evaluation of routine, and open lines with environmental oversight groups keep our efforts honest and measured by real progress, not just intent.
Each month, researchers share project updates and feedback, pointing out where our product holds up under real pressure or where refinements could move science forward. The partnership model works when both sides—producer and researcher—believe their feedback prompts change. Our internal engineering groups have already adapted drying and handling steps to support work requiring sterile or ultra-low moisture product, a step initiated by discussion with pharmaceutical clients.
New models for on-demand synthesis or just-in-time supply are under review as clients request smaller, more frequent shipments with real-time documentation uploads. Sharing production insights, stabilizing variability, and continuing to innovate in response to research needs have shaped not just this compound, but the way we see our role supporting scientific progress as manufacturers and stewards of chemical innovation.
Some in the field believe any lab-scale compound looks the same, batch after batch. Experience has shown otherwise. Single-point improvements in the handling, filtration, or salt formation step often create tangible gains in daily lab use, recovery rates, and time savings. By aligning production with reality in the research lab, our manufacturing adapts not to the broadest common denominator, but to the actual hurdles and requests voiced by those using our work as the raw material for their science.
In the journey from design to delivered product, workers on the production floor see firsthand which steps build value and which introduce problems. Through this lived experience, we recognize that details—often invisible to outsiders—shape the work that happens far beyond our doors. We share those lessons with every scientist and partner who chooses our compound, aiming to make every gram as reliable as if we were using it ourselves.